Issues
Volume 219 Issue 9
News
New Australian guidelines for diabetes-related foot disease
New Australian-based guidelines for diabetes-related foot disease have been summarised in an article recently published online at the Medical Journal of Australia (MJA), coinciding with World Diabetes Day on 14 November 2023. The guidelines, developed and published by Diabetes Feet Australia, are the first new Australian guidelines since 2011 and have been endorsed by ten national peak bodies. “We’ve observed over the years that well-directed implemented guidelines are critical to underpinning quality care and there are a number of areas of the guidelines that have been improved and updated compared with the ones from 2011,” guideline summary co-author Professor Stephen Twigg. “Practically developed clinical care guidelines that are up to date can really make a positive difference to health care outcomes and, in this case, for people with foot disease,” he said. The theme of this year’s World Diabetes Dayis “Know your risk, know your response”, encouraging people to know their risk level and what to do to support prevention, early diagnosis and timely treatment. Diabetes-related foot disease is a leading cause of hospitalisation, amputation, disability and health care costs in Australia. It is estimated that 300 000 Australians are at risk of developing diabetes-related foot disease annually. The guidelines at a glance The 98 recommendations made across six new guidelines for the general medical audience have been summarised in the MJA: prevention — screening, education, self-care, footwear, and treatments to prevent diabetic foot disease;classification — classifications systems for ulcers, infection, ischaemia and auditing;peripheral artery disease — examinations and imaging for diagnosis, severity classification, and treatments;infection — examinations, cultures, imaging and inflammatory markers for diagnosis, severity classification, and treatments;offloading — pressure offloading treatments for different ulcer types and locations; andwound healing — debridement, wound dressing selectionThe changes include a new risk stratification system for screening of people without diabetes-related foot disease, with more specific self-monitoring, footwear prescription, surgical treatments and activity management practices for those at increased risk. For people with diabetes-related foot disease, there are new ulcer, infection and peripheral artery disease classification systems, with more specific recommendations to resolve diabetes-related foot disease. Diabetes Feet Australia has created an interactive platform for the guidelines, which health care practitioners can use with their patients. “GPs or podiatrists or nurses with a patient with diabetes-related foot disease in front of them can click on these pathways to identify the recommendations that apply for that particular patient in terms of assessment, education and management,” guideline summary co-author Associate Professor Pete Lazzarini said.
Annika Howells
Indigenous research wins MJA Award for Excellence in Medical Research
Research looking at the life expectancy of Indigenous and non-Indigenous people in the Northern Territory has won the 2022 Medical Journal of Australia (MJA) Award for Excellence in Medical Research. The research, conducted by Dr Yuejen Zhao, Shu Qin Li, Dr Tom Wilson, and Professor Paul Burgess, found that life expectancy for Indigenous people in the NT improved markedly from 1999 to 2018, with fewer lives lost to cancer, injuries and chronic disease. The MJA Editor-in-Chief, Professor Virginia Barbour, congratulated the team, saying they were worthy recipients of the award. “I congratulate Dr Zhao, Shu Qin Li, Dr Wilson, and Professor Burgess for winning the MJA Award for Excellence in Medical Research,” Professor Barbour said. “Their important research has helped contribute to the growing Australian academic literature about Indigenous health and wellbeing. “We know that more needs to be done to improve the health outcomes for Aboriginal and Torres Strait Islander people, so the MJA really encourages more research into this area. “It is also vital that the research community recognises the importance of research into the health and wellbeing of Aboriginal and Torres Strait Islander people, and here at MJA, we are proud to do that through this award.” Co-author Professor Paul Burgess, the Senior Director of Health Statistics and Informatics at NT Health, said the team were honoured to receive the award. “We are delighted and humbled to accept the MJA award for Excellence in Medical Research,” Professor Burgess said on behalf of the team. “As public health officials, we generally eschew the limelight — outside the occasional pandemic! “However, we think the true recognition for this work belongs to the many Aboriginal and non-Aboriginal people who have volunteered or worked tirelessly over the past 20 years to improve health outcomes across the NT.” Their research is part of a burden of disease study conducted every five years, Professor Burgess said. “Every five years we undertake the NT burden of disease study to understand the changing demands on the NT health system and also capture health outcomes through analysis of causes of mortality. “We use our burden of disease work as evidence to guide policy and program development in NT Health. “For our research, we were interested to see if there were changes in life expectancy in the NT population and in what disease areas these changes were occurring.” The research found that the life expectancy gap between Aboriginal and non-Aboriginal Territorians has closed significantly over the past 20 years — by 26% for men and by 21% for women. “In our research, we estimated, at the current pace of improvement, it would take another 60 years to close the gap in life expectancy between Aboriginal and non-Aboriginal Territorians,” Professor Burgess said. “Clearly, we can and should do better than this. “We have shown that life expectancy gains are achievable and that with further investment across health and the social determinants, we could expect to fast-track further improvements. “Critically, we need to listen to and partner with Aboriginal communities to address their priorities for action.” Professor Burgess hoped the research could help accelerate efforts to improve health and social outcomes for Aboriginal and Torres Strait islander people. “While our epidemiological research has not contributed directly to health gains, we have validated the efforts of the many Aboriginal and non-Aboriginal people that are working to improve outcomes every day across health, education, justice, housing and a myriad of non-government organisations,” Professor Burgess said. “It would be wonderful if our work could instil hope and perseverance for frontline workers and stimulate further investment to accelerate closing the gap in health and social outcomes. “Real change is absolutely possible.”
Sam Hunt
Editor’s choice
Cancer care and outcomes through a health equity lens
This issue of the MJA focuses on cancer, with a wide spectrum of research, commentary and clinical reports in this area. Articles include perspectives on lung cancer screening for Aboriginal and Torres Strait Islander people (doi: 10.5694/mja2.52084) and the impact of COVID‐19 on cancer outcomes in Australia (doi: 10.5694/mja2.52125); and research on treatment intervals and survival for women diagnosed with early breast cancer in Queensland (doi: 10.5694/mja2.52091) and health care service use by people diagnosed with invasive melanoma (doi: 10.5694/mja2.52122). The perspective by Brown and colleagues on lung cancer screening for Aboriginal and Torres Strait Islander people discusses the opportunities to address health inequities when the Australian national Lung Cancer Screening Program begins in July 2025 (doi: 10.5694/mja2.52084). The authors point out that both age‐adjusted rate and deaths from lung cancer are “double the rates found in non‐Indigenous populations”, with lung cancer being the both the most common cancer and the leading cause of cancer death in Aboriginal and Torres Strait Islander people. They note that “The disproportionate lung cancer burden means that [a Lung Cancer Screening Program] could deliver greater benefits to Aboriginal and Torres Strait Islander communities and reduce the disparity with non‐Indigenous Australians”. However, as they further note, “An understanding of historical and cultural contexts of Aboriginal and Torres Strait Islander wellbeing in a settler colonial state is essential” and will be crucial to realising these benefits. The perspective by Canfell and colleagues on the impact of COVID‐19 on cancer outcomes in Australia is a good reminder that the effects of COVID‐19 will be with us for a long time (doi: 10.5694/mja2.52125). The results are complex although largely reassuring: the authors note that “although health services were disrupted and there is evidence that the pandemic affected cancer screening, diagnosis and treatment services in Australia, there is no indication yet of increased cancer mortality at a whole‐of‐population level”. However, as the authors conclude, long term review and analysis will be needed — at national and state level — to fully understand the impact, especially as we do not yet have national cancer registration data for 2020. Furthermore, the authors observe we must “consider that COVID‐19 may have exposed and exacerbated existing gaps in detection and cancer care, particularly for those already experiencing disadvantage”. The research by Lindsay and colleagues is an analysis according to residential socio‐economic disadvantage and remoteness of health care service use by Queenslanders with primary diagnoses of invasive melanoma — a cancer with a high incidence in Australia, and especially high incidence in Queensland (doi: 10.5694/mja2.52122). Their results are hopeful, showing that there are relatively minor differences in health care service use and that access to health care for people with melanoma is fairly equitable in Queensland. However, the authors note that “Optimising service delivery to ensure maximal health benefits for everyone should remain the goal, using frameworks for reducing inequity in health care, such as the [yet to be published] Australian Cancer Plan” — a conclusion that underscores the importance of including a health equity lens across all of health care and medical research.
Virginia Barbour
Perspectives
Lung cancer screening for Aboriginal and Torres Strait Islander peoples: an opportunity to address health inequities
A commitment to culturally appropriate codesign processes will shape the development of an equitable lung cancer screening pathway
Alison Brown · Gail Garvey · Nicole M Rankin · Claire Nightingale · Lisa J Whop
The complex impact of COVID‐19 on cancer outcomes in Australia
The pandemic’s ultimate impact on cancer outcomes is likely to be multifaceted
Karen Canfell · Karen Chiam · Carolyn Nickson · G Bruce Mann
Medical education
Good's syndrome associated with multiple basal cell carcinomas: a case report
A 61-year-old man of European ancestry presented with five large fungating lesions
Michelle Wu · Nicole Seebacher · Margit Polcz
Editorial
The importance of early breast cancer treatment: delay can be deadly
The study by Kou and colleagues provides support for the current Cancer Australia breast cancer treatment guidelines
Nicholas R Wilcken
Research
Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population‐based cohort study
Findings support the treatment timeframes recommended as timely in the 2020 guidelines
Kou Kou · Joanne F Aitken · Christopher Pyke · Suzanne Chambers · Jeff Dunn · Peter D Baade
Health care service use by people diagnosed with invasive melanoma in Queensland: a benefit incidence analysis
Residential location does not markedly influence access to health services for Queenslanders with melanoma
Daniel Lindsay · David C Whiteman · Catherine M Olsen · Louisa G Gordon
Study protocol
Psychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trial
Robust evidence is needed for future mammography population screening practice and policy
Brooke Nickel · Nick Ormiston‐Smith · Lisa Hammerton · Erin Cvejic · Paul Vardon · Zoe Mcinally · Paula Legerton · Karen Baker · Jennifer Isautier · Emma Larsen · Michelle Giles · Meagan E Brennan · Kirsten J McCaffery · Nehmat Houssami
Research letter
Preventive health checks in Australian general practice for women during mid‐life
GPs proactively provide preventive health care to those most in need, partly because of sufficiently high rebate levels
Louise F Wilson · Annette J Dobson · Gita D Mishra · Jenny A Doust
Narrative review
Hepatocellular carcinoma surveillance in Australia: current and future perspectives
Hepatocellular carcinoma is a leading cause of cancer-related death worldwide, and is increasing in incidence in Australia
Samuel Hui · Sally Bell · Suong Le · Anouk Dev
Letters
Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support
Deborah Gleeson · James Scheibner · Dianne Nicol
Erratum
Erratum
Hla TK, Cannon JW, Bowen AC, Wyber R. Getting to grips with invasive group A streptococcal infection surveillance in Australia: are we experiencing an epidemic? Med J Aust 2023; 219 (6): 242‐245. https://doi.org/10.5694/mja2.52056. In this article, the final sentence under the heading “Inequitable epidemics” should read: “Although Indigenous status is not available in the publicly accessible National Notifiable Disease Surveillance System dataset, it is a core field and there is capacity for states and territories to report this information, to assess progress of this inequitable epidemic across Australia.”
Endocrinology then and now
Virginia Barbour
Glucocorticoid‐induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning
David J Torpy · Wu Tzen Lim
Is remission of type 2 diabetes mellitus real?
Stephen N Stranks · Gary A Wittert
Setting the policy agenda for cancer control reform: Australia's first national cancer control plan
Daniel Chaji · Anna Boltong · Carolyn Der Vartanian · Adam Lambert · Cindy Toms · Vivienne Milch · Claire Howlett · Dorothy Keefe
Diabetes and non‐alcoholic fatty liver disease: a bittersweet symphony
Daniel Clayton‐Chubb · Stuart K Roberts
Dietary management of eosinophilic oesophagitis
Jessica Fitzpatrick · Sarah L Melton · Rebecca E Burgell